APA (7th ed.) Citation

S, J., G, F., S, G., E, A., D, K., TA, G., . . . 3rd, B. H. (2026). A Phase II Study to Evaluate the Efficacy of Commercially Available Molecularly Matched Targeted Therapies in the Second-Line Setting. The oncologist. https://doi.org/10.1093/oncolo/oyag279

Chicago Style (17th ed.) Citation

S, Jones, Falchook G, Graff S, Arrowsmith E, Kilari D, Gersten TA, Hussein M, Percent I, and Burris HA 3rd. "A Phase II Study to Evaluate the Efficacy of Commercially Available Molecularly Matched Targeted Therapies in the Second-Line Setting." The Oncologist 2026. https://doi.org/10.1093/oncolo/oyag279.

MLA (9th ed.) Citation

S, Jones, et al. "A Phase II Study to Evaluate the Efficacy of Commercially Available Molecularly Matched Targeted Therapies in the Second-Line Setting." The Oncologist, 2026, https://doi.org/10.1093/oncolo/oyag279.